Status:
UNKNOWN
A Cohort Study on the Clinical Characteristics and Prognosis of HIV/AIDS Patients Infected With SARS-CoV-2
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Conditions:
PLWH
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
On February 11th, 2020, the International Classification of Viruses named the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as novel coronavirus (COVID-19, Covid-19 fo...
Eligibility Criteria
Inclusion
- Age 18-75 years old; Patients diagnosed with HIV in accordance with the Chinese AIDS Diagnosis and Treatment Guidelines.
Exclusion
- Hypertension, diabetes and other metabolic related diseases; Severe circulatory and respiratory diseases; Patients with immune-related diseases and immunosuppressants; Pregnant and lactating women.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06172816
Start Date
January 1 2023
End Date
December 31 2024
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The second affiliated hospital of Chongqing medical university
Chongqing, Chongqing Municipality, China, 400010